This is a prospective, three-arm, parallel-group, assessor-blinded randomized controlled trial designed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) combined with pelvic floor muscle training (PFMT), pulsed electromagnetic field stimulation (PEMF) combined with PFMT, and PFMT alone in Females with sexual dysfunction. Participants will be randomly allocated in a 1:1:1 ratio, and the study duration is 16 weeks, including an 8-week intervention period and an 8-week follow-up period.
Female participants aged 20-50 years diagnosed with female sexual dysfunction (FSFI score <26.55), reporting symptoms of reduced sexual desire, arousal dysfunction, orgasmic dysfunction, or dyspareunia.
Premenopausal women in a stable sexual relationship for at least 6 months and sexually active during the previous month.
Symptoms persisting for at least 3 months before enrollment.
Ability to understand study procedures and provide written informed consent.
Pregnancy or planned pregnancy during the study period.
Pelvic surgery within the previous 6 months.
Active pelvic inflammatory disease, genital infection, or unexplained vaginal bleeding.
Neurological disorders affecting pelvic floor or sexual function.
Benha University
Lead sponsor
Beni-Suef University
Collaborator